The Head of Strategy & Portfolio - Small Molecules is the segment owner for strategy and portfolio decisions, accountable for defining where to play, how to win, and how to allocate capital across the Small Molecules business. The role drives organic and inorganic growth by translating market, customer, and financial insights into clear portfolio choices and investment priorities, while partnering closely with Marketing, Sales, Finance, Science, and Operations to ensure disciplined execution aligned with Solvias' growth ambitions.
Solvias is a global provider of chemistry, manufacturing, and control (CMC) analytics to the life sciences industry. Our expert team combines decades of experience with regulatory expertise across small molecules, biologics, and cell and gene therapies. Solvias offers end-to-end solutions from raw material testing to drug product release and API development for small molecules. Headquartered near Basel, Switzerland, Solvias operates six global Centers of Excellence, all adhering to the highest ISO, GMP, GLP, and FDA standards